KR20200140836A - 십이지장 브루너샘으로부터의 줄기/전구 세포 및 이들의 단리 및 사용 방법 - Google Patents

십이지장 브루너샘으로부터의 줄기/전구 세포 및 이들의 단리 및 사용 방법 Download PDF

Info

Publication number
KR20200140836A
KR20200140836A KR1020207030724A KR20207030724A KR20200140836A KR 20200140836 A KR20200140836 A KR 20200140836A KR 1020207030724 A KR1020207030724 A KR 1020207030724A KR 20207030724 A KR20207030724 A KR 20207030724A KR 20200140836 A KR20200140836 A KR 20200140836A
Authority
KR
South Korea
Prior art keywords
cells
population
cell
medium
bgsc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020207030724A
Other languages
English (en)
Korean (ko)
Inventor
귀도 카르피노
빈센조 카르디날레
로라 엠. 레이드
도메니코 알바로
에우제니오 가우디오
Original Assignee
더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐
사피엔자 유니버시타 디 로마
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐, 사피엔자 유니버시타 디 로마 filed Critical 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐
Publication of KR20200140836A publication Critical patent/KR20200140836A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0679—Cells of the gastro-intestinal tract
    • C12N5/068—Stem cells; Progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C12N2509/10—Mechanical dissociation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2521/00—Culture process characterised by the use of hydrostatic pressure, flow or shear forces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2527/00—Culture process characterised by the use of mechanical forces, e.g. strain, vibration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062—General methods for three-dimensional culture

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020207030724A 2018-03-29 2019-03-28 십이지장 브루너샘으로부터의 줄기/전구 세포 및 이들의 단리 및 사용 방법 Ceased KR20200140836A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862650208P 2018-03-29 2018-03-29
US62/650,208 2018-03-29
PCT/US2019/024543 WO2019191402A1 (en) 2018-03-29 2019-03-28 Stem/progenitor cells from duodenal brunner's glands and methods of isolating and using them

Publications (1)

Publication Number Publication Date
KR20200140836A true KR20200140836A (ko) 2020-12-16

Family

ID=68054860

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020207030724A Ceased KR20200140836A (ko) 2018-03-29 2019-03-28 십이지장 브루너샘으로부터의 줄기/전구 세포 및 이들의 단리 및 사용 방법

Country Status (15)

Country Link
US (1) US20190300849A1 (cg-RX-API-DMAC10.html)
EP (1) EP3781181A4 (cg-RX-API-DMAC10.html)
JP (2) JP7562416B2 (cg-RX-API-DMAC10.html)
KR (1) KR20200140836A (cg-RX-API-DMAC10.html)
CN (1) CN112272698A (cg-RX-API-DMAC10.html)
AR (1) AR115304A1 (cg-RX-API-DMAC10.html)
AU (1) AU2019242887A1 (cg-RX-API-DMAC10.html)
BR (1) BR112020019773A2 (cg-RX-API-DMAC10.html)
CA (1) CA3112650A1 (cg-RX-API-DMAC10.html)
IL (2) IL311366B2 (cg-RX-API-DMAC10.html)
MX (1) MX2020010223A (cg-RX-API-DMAC10.html)
PH (1) PH12020551584A1 (cg-RX-API-DMAC10.html)
SG (1) SG11202009428YA (cg-RX-API-DMAC10.html)
TW (1) TW202002997A (cg-RX-API-DMAC10.html)
WO (1) WO2019191402A1 (cg-RX-API-DMAC10.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025164891A1 (ko) * 2024-01-29 2025-08-07 (의) 삼성의료재단 중간엽 줄기세포 유래 췌도 오가노이드의 제조방법, 이에 따른 췌도 오가노이드 및 이를 이용한 당뇨 관련 질환 치료제를 스크리닝하는 방법

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10202104575WA (en) 2016-11-04 2021-06-29 Childrens Hospital Med Ct Liver organoid compositions and methods of making and using same
CA3106634A1 (en) 2018-07-26 2020-01-30 Children's Hospital Medical Center Hepato-biliary-pancreatic tissues and methods of making same
CN112823012A (zh) 2018-09-12 2021-05-18 儿童医院医学中心 用于产生造血干细胞及其衍生物的类器官组合物
WO2020160371A1 (en) 2019-02-01 2020-08-06 The University Of Hong Kong Innervated organoid compositions and methods of making same
CA3141807A1 (en) 2019-05-31 2020-12-03 Children's Hospital Medical Center Methods of generating and expanding hematopoietic stem cells
US12534709B2 (en) 2019-05-31 2026-01-27 Children's Hospital Medical Center Shaped organoid compositions and methods of making same
KR102322635B1 (ko) * 2021-06-11 2021-11-05 인제대학교 산학협력단 말초신경양 미세조직 제조방법 및 이의 용도
AU2022304681A1 (en) * 2021-07-02 2024-01-25 Children’S Hospital Medical Center Structurally complete organoids
WO2023171702A1 (ja) * 2022-03-08 2023-09-14 慶應義塾 オルガノイドの製造方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002057430A2 (en) * 2001-01-20 2002-07-25 Cardion Ag Pluripotent adult stem cells derived from regenerative tissue
US20050256077A1 (en) 2004-03-30 2005-11-17 Henning Susan J Gastrointestinal stem cells and uses thereof
US20070026520A1 (en) * 2005-07-29 2007-02-01 Kelly James H Novel cells, compositions, and methods
US20070128584A1 (en) 2005-12-01 2007-06-07 Illani Atwater Method for isolation of cells
CN101668848B (zh) * 2007-04-26 2014-10-22 雷蒙特亚特特拉维夫大学有限公司 来自口腔粘膜的多能自体干细胞和使用方法
US20090269769A1 (en) 2008-04-23 2009-10-29 Asit Panja Drug Discovery Methods Involving A Preclinical, In Vitro Isolated Gastrointestinal Epithelial Stem Cell-Like Progenitor Cell System
EP2326336B1 (en) * 2008-07-30 2015-05-13 Mesynthes Limited Tissue scaffolds derived from forestomach extracellular matrix
US8895300B2 (en) * 2008-11-04 2014-11-25 Viacyte, Inc. Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof
US8367316B2 (en) * 2009-05-01 2013-02-05 Alfagene Bioscience, Inc. Human gastrointestinal stem cell-derived primary intestinal epithelial cell system and methods of use thereof
ES2819028T3 (es) * 2009-10-30 2021-04-14 Univ North Carolina Chapel Hill Células madre multipotentes del árbol biliar extrahepático y métodos para su aislamiento
WO2012070014A2 (en) * 2010-11-26 2012-05-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Identification of novel cell surface markers for pancreatic progenitor cells and definite endodermal cells
US9533013B2 (en) * 2013-03-13 2017-01-03 University Of North Carolina At Chapel Hill Method of treating pancreatic and liver conditions by endoscopic-mediated (or laparoscopic-mediated) transplantation of stem cells into/onto bile duct walls of particular regions of the biliary tree
CN105087479A (zh) * 2015-08-21 2015-11-25 深圳爱生再生医学科技有限公司 干细胞无血清培养基及干细胞的培养方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025164891A1 (ko) * 2024-01-29 2025-08-07 (의) 삼성의료재단 중간엽 줄기세포 유래 췌도 오가노이드의 제조방법, 이에 따른 췌도 오가노이드 및 이를 이용한 당뇨 관련 질환 치료제를 스크리닝하는 방법

Also Published As

Publication number Publication date
BR112020019773A2 (pt) 2021-02-17
CA3112650A1 (en) 2019-10-03
IL277552B1 (en) 2024-04-01
IL311366B1 (en) 2025-01-01
SG11202009428YA (en) 2020-10-29
MX2020010223A (es) 2021-01-15
IL277552B2 (en) 2024-08-01
JP7562416B2 (ja) 2024-10-07
EP3781181A1 (en) 2021-02-24
JP2021519585A (ja) 2021-08-12
IL311366B2 (en) 2025-05-01
JP2024075687A (ja) 2024-06-04
EP3781181A4 (en) 2021-12-29
IL277552A (en) 2020-11-30
US20190300849A1 (en) 2019-10-03
AU2019242887A1 (en) 2020-11-12
PH12020551584A1 (en) 2021-09-13
CN112272698A (zh) 2021-01-26
IL311366A (en) 2024-05-01
WO2019191402A1 (en) 2019-10-03
AR115304A1 (es) 2020-12-23
TW202002997A (zh) 2020-01-16

Similar Documents

Publication Publication Date Title
JP7562416B2 (ja) 十二指腸ブルンナー腺由来の幹/前駆細胞ならびにそれらの単離および使用方法
JP7706785B2 (ja) 腎臓病治療のための免疫特権を有する生物活性腎細胞
JP7854806B2 (ja) 幹細胞/前駆体の固形器官へのパッチ移植
WO2021021503A1 (en) Use of alveolar or airway organoids for the treatment of lung diseases and disorders
US10479977B2 (en) Osteochondroreticular stem cells for bone and cartilage regeneration
CN110662563A (zh) 可注射细胞和支架组合物
JP2022505032A (ja) 腫瘍オルガノイドを産生するための組成物および腫瘍オルガノイドを産生する方法
JP2022545376A (ja) 硝子軟骨組織のin vitroでの産生のための方法
KR20230157969A (ko) 담관세포를 확장하는 방법
HK40037652A (en) Stem/progenitor cells from duodenal brunner's glands and methods of isolating and using them
RU2816753C2 (ru) Иммунологически привилегированные биоактивные почечные клетки для лечения заболевания почек
Meran et al. Engineering transplantable jejunal mucosal grafts using primary patient-derived organoids from children with intestinal failure
CN119405697A (zh) 一种促进关节修复的软骨干细胞及其应用
BR122024023993A2 (pt) Método de produção de uma célula renal bioativa genomicamente modificada (brc), brc engenheirada e seu uso
HK40025177A (en) Immunoprivileged bioactive renal cells for the treatment of kidney disease

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20201026

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20220325

Comment text: Request for Examination of Application

PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20240927

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20241204

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D